SCHEMBL9706714

SCHEMBL9706714

FC(F)=C(F)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)Br

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9706656 0.93 LMNA (0.32) LMNA
SCHEMBL4443070 0.87
SCHEMBL10036824 0.85
SCHEMBL10036823 0.85
SCHEMBL10036811 0.85
SCHEMBL10036822 0.85
SCHEMBL10036813 0.85
SCHEMBL10036812 0.85
SCHEMBL51457 0.82
SCHEMBL10036810 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118530099-A Preparation method of perfluoro iodine-containing vulcanization point monomer 中国科学院上海有机化学研究所 2024-08-23 CN claimed
WO-2025137516-A1 FLUORINATED MONOMERS, ANION EXCHANGE POLYMERS AND METHODS OF MAKING THE SAME THE CHEMOURS COMPANY FC, LLC (US) 2025-06-26 WO disclosed
US-12168647-B2 Functionalized triazine compounds, compositions comprising such compounds and cured fluoropolymer articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-12-17 US disclosed
CN-118530099-A Preparation method of perfluoro iodine-containing vulcanization point monomer 中国科学院上海有机化学研究所 2024-08-23 CN disclosed
CN-118373730-A Fluorine-containing ether compound, fluorine-containing ether composition, coating liquid, article, method for producing article, and method for producing fluorine-containing compound AGC株式会社 2024-07-23 CN disclosed
CN-118307391-A Fluorine-containing ether compound, fluorine-containing ether composition, coating liquid, article, method for producing article, and method for producing fluorine-containing compound AGC株式会社 2024-07-09 CN disclosed
US-11926756-B2 Fluorine-containing ether compound, fluorine-containing ether composition, coating liquid, article, method for producing article, and method for producing fluorine-containing compound AGC Inc. (JP) 2024-03-12 US disclosed
EP-3990439-B1 FUNCTIONALIZED TRIAZINE COMPOUNDS, COMPOSITIONS COMPRISING SUCH COMPOUNDS AND CURED FLUOROPOLYMER ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-12-06 EP disclosed
US-20220235016-A1 Functionalized Triazine Compounds, Compositions Comprising Such Compounds and Cured Fluoropolymer Articles 3M INNOVATIVE PROPERTIES COMPANY 2022-07-28 US disclosed
EP-3990439-A1 FUNCTIONALIZED TRIAZINE COMPOUNDS, COMPOSITIONS COMPRISING SUCH COMPOUNDS AND CURED FLUOROPOLYMER ARTICLES 3M Innovative Properties Company (US) 2022-05-04 EP disclosed
US-5151492-A Fluorine containing homopolymers or copolymers NIPPON MEKTRON, LIMITED (JP) 1992-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11926756-B2 Fluorine-containing ether compound, fluorine-containing ether composition, coating liquid, article, method for producing article, and method for producing fluorine-containing compound SEC13, FOS, RPL13 LMNA 910/4885
US-20220235016-A1 Functionalized Triazine Compounds, Compositions Comprising Such Compounds and Cured Fluoropolymer Articles AFF2, AFF1, AFF4 LMNA 2458/4885
US-12168647-B2 Functionalized triazine compounds, compositions comprising such compounds and cured fluoropolymer articles AFF2, AFF1, AFF4 LMNA 2458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.